Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Independence from the rat race: How to Save and Contribute Shrewdly - 2Landon Donovan knew he couldn’t hide his hair loss. So he turned to fans for help.
- 3Lilly becomes first healthcare firm to join trillion-dollar club, Wall Street reacts
- 4The most effective method to Connect Successfully with Teachers in a Web based Setting
- 5The Meaning of Breaking the Pen's Nib in Death penalties
- Vote in favor of Your #1 4\u00d74 SUVs
- Bother Control Administrations for 2024: Decide for Your Home
- How a Snake That Eats Cobras Redefined the Meaning of ‘King’
- The cheap health insurance promoted by Trump officials has this catch
- Stop the ‘good’ vs ‘bad’ snap judgments and watch your world become more interesting
- The Force of Positive Reasoning: Day to day Attestations
- Home Wellness Basics: Building Your Home Exercise center
- Pick Your #1 Sort Of Espresso
- All that You Really want to Be familiar with Dental Inserts Facilities
